
Marc Brisson
Chercheur universitaire
Axe Santé des populations et pratiques optimales en santé
Dernières nouvelles
Voir toutPublications
Voir tout-
article Laprise JF, Chesson HW, Markowitz LE, Drolet M, Brisson M
Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the Uni…
Ann Intern Med 178 (1), 2025.
-
article Burger EA, Laprise JF, Portnoy A, Spencer JC, Sy S, Regan MC, Bénard É and Drolet M, Brisson M, Kim JJ
Population-level health impact of hypothetical waning 1-dose human papillomavirus vaccination and 2-dose mitigation strategies in a high cervical cancer burden setting
J Natl Cancer Inst Monogr 2024 (67), 2024.
-
article Whitworth HS, Mounier-Jack S, Choi EM, Gallagher KE, Howard N, Kelly H, Mbwanji G, Kreimer AR, Basu P, Barnabas R, Drolet M, Brisson M, Watson-Jones D
Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to multidose vaccination regimens or no vaccination: An updated systematic review of eviden…
Vaccine X 19 2024.
Projets
- Scalable, Customizable, Digital Health Communication Materials to Help Canada Address the COVID19 Pandemic, du 2020-06-01 au 2025-03-31
- Optimization of HPV vaccination and screening in Canada, considering opportunities provided by 1-dose vaccination: A mathematical modeling study, du 2023-04-01 au 2025-03-31
- Impact du biais de déplétion différentielle des susceptibles sur l'estimation de l' efficacité terrain des vaccins à partir de données populationnelles, du 2023-09-01 au 2025-12-31
- Mathematical Modeling and Health Economics of Infectious Diseases, du 2024-10-01 au 2031-09-30
- Optimizing HPV vaccination programs in Low- and Middle-Income Countries (LMIC) and Canada to reduce inequalities and reach global elimination of cervical cancer: An integrated knowledge translation dynamic-modeling approach, du 2024-10-01 au 2028-09-30
- Understanding the pathogenesis of COVID-19, du 2020-03-01 au 2023-02-28
- Elimination of cervical cancer through vaccination and screening in high HIV prevalence settings: a mathematical modeling and cost effectiveness study, du 2019-10-01 au 2024-03-31
- PC09, QC23, Engage-HPV: Human papillomavirus prevention for gay, bisexual and other men who have sex with men in Vancouver, Toronto, and Montreal, du 2021-04-01 au 2023-03-31
- CONNECT - contacts sociaux et sexuels, du 2022-02-01 au 2025-01-31
- Modélisation mathématique de l'épidémie à Covid-19 au Québec 2022-2023, du 2022-03-01 au 2024-03-31
- Accelerating Cervical Cancer Elimination in Canada: ACE-Canada, du 2020-01-01 au 2024-12-31
- Optimizing HPV vaccination programs in Low- and Middle-Income Countries (LMIC) and High-Income Countries (HIC) to reduce inequalities and reach global elimination of cervical cancer: An integrated knowledge translation dynamic-modeling, du 2024-03-01 au 2025-02-28